Searchable abstracts of presentations at key conferences in endocrinology

ea0038p235 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Relationship between high-sensitivity C-reactive protein and anthropometric indices of obesity

Soyoye David , Kolawole Babatope , Ikem Rosemary , Enikuomehin Adenike

Background: Obesity contributes to the occurrence of many metabolic and cardiovascular complications including Type 2 diabetes, hypertension etc. Body adiposity is not just an energy store, but also an endocrine organ with elaboration of hormones and cytokines. Some of these cytokines have been implicated in the initiation and propagation of inflammation, and hence atherosclerosis.Aim: This study examined the relationship between high-sensitivity C-react...

ea0025p351 | Thyroid | SFEBES2011

Thyroid dysfunction in patients receiving interferon treatment for hepatitis C: an audit

Sugunendran Suma , Verghese Jeanny , Aye Mo , Sathyapalan Thozhukat , Abouda George , Mohamed Kamrudeen

Aims and objective: Pegylated interferon is widely used in the treatment of hepatitis C. Thyroid dysfunction (TD) is a well recognised side effect of interferon treatment. As the use of interferon therapy in hepatitis C is on the rise, we conducted an audit to determine its prevalence and to formulate local guidelines for the monitoring and management of thyroid dysfunction in these patients.Methods: A case note based retrospective audit of all patients ...

ea0022p549 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

IGF(CA)19 and IGFBP-3-202A/C gene polymorphism in patients with acromegaly

Akin Fulya , Turgut Sebahat , Cirak Bayram , Kursunluoglu Raziye

Aims: We aimed to investigate IGF1 and IGFBP3 gene polymorphisms in patients with acromegaly.Methods: We included 34 patients with acromegaly and 37 healthy subjects to study. At baseline examinations, antropometric measurements were done. Genomic DNA from the patients and controls were prepared. Serum, glucose, insulin, total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, GH, IGF1 and IGFBP3 levels of subjects were analyzed.<p class="a...

ea0016p572 | Obesity | ECE2008

Activated protein C levels in obesity and weight loss influence

Sola Eva , Espana Francisco , Vaya Amparo , Estelles Amparo , Garcia Katherinne , Hernandez-Mijares Antonio

Introduction: Several haemostatic disturbances have been described in obese patients. Nevertheless, the state of coagulation inhibitors has been scarcely studied in these patients. Activated protein C (APC) is the anticoagulant enzyme formed upon activation of the protein C (PC) by the thrombin-thrombomodulin complex on the surface of endothelial cells. Morbid obesity is associated to endothelial dysfunction, which could cause a reduction in APC generation.<p class="abstex...

ea0009oc27 | Oral Communication 4: Steroids | BES2005

Interaction of the ACTH receptor C-terminal tail with a nuclear envelope protein

Doufexis M , Clark A

Adrenocorticotrophic hormone (ACTH), a 39 amino acid peptide is the principal regulator of adrenal steroidogenesis and is thus essential for life. ACTH mediates its effects through a cell surface G-protein coupled receptor which elevates the intracellular production of cAMP through adenylate cyclase. There have been significant difficulties in developing a suitable heterologous expression system to study the ACTH receptor (or melanocortin 2 receptor - MC2R), and we have postul...

ea0073aep278 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Response to direct antiviral agents in chronic hepatitis C in patients with metabolic syndrome

Soumaya Mrabet , raida harbi , Akkari Imen , Elhem Ben Jazia

IntroductionDirect antiviral agents (DAAs) are a real revolution in the treatment of chronic hepatitis c (CHC). It is a short-term treatment with few side effects. Insulin resistance in patients with metabolic syndrome, causes the onset of steatosis, contributes to the progression to cirrhosis and decreases the chances of a response to treatment. The aim of our study was to evaluate the response to DAAs in patients with metablic syndrome.<p class="ab...

ea0015s35 | Evolving endocrine targets for C-type natriuretic peptide (CNP) | SFEBES2008

Novel cardiovascular roles for CNP

Villar C

C-type natriuretic peptide (CNP) represents a key paracrine member of the natriuretic peptide family that play an important role in the regulation of vascular tone and local blood flow. CNP is found abundantly in vascular endothelial cells and it is now clear that CNP can be released from the endothelium to act on adjacent cells, both in the vessel wall and the circulation. Thus, it has been shown that CNP hyperpolarises and dilates vascular smooth muscle in the mammalian resi...

ea0065p136 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Profiling of tissue inflammatory cytokine expression in a pancreatic neuroendocrine tumour mouse model identifies upregulation of the chemokine C-C motif ligand 2 (CCL2)

Shariq Omair , Lines Kate , Stevenson Mark , Thakker Rajesh

Pancreatic neuroendocrine tumours (PNETs) may occur as part of the multiple endocrine neoplasia type 1 (MEN1) syndrome, or as a non-familial isolated endocrinopathy. Current medical treatments for PNETs are largely ineffective in preventing tumour progression, so there is a need for better therapies, which will develop from an improved understanding of the mechanisms driving PNET tumorigenesis. Cytokine-driven inflammation has been implicated in the development and progression...

ea0077oc5.3 | Bone and Calcium | SFEBES2021

Role of Intact and C-Terminal FGF-23 Assays in the Investigation of Metabolic Bone Disease.

Jethwa Kishan , Bhatti Sumbal , Chipchase Allison , Piec Isabelle , Fraser William , Turner Jeremy

Fibroblast growth factor 23 (FGF-23) is a phosphatonin produced by osteocytes in response to serum phosphate concentration. Immunoassays are widely employed to detect C-terminal fragments of FGF-23 (cFGF-23). Quantitative assays for intact FGF-23 (iFGF-23) measurement are also available. Causes of increased FGF-23 include Tumour Induced Osteomalacia (TIO), X-linked hypophosphataemic rickets (XLH) and end stage renal disease (ESRD). We observed that some individuals, with no id...

ea0056oc6.3 | Genetic and environmental determinants of obesity and insulin resistance | ECE2018

Visceral fat assessment in lamin A/C mutation carriers: phenotype –genotype correlation

Kwapich Maxime , Espiard Stephanie , Le Mapihan Kristell , Vigouroux Corinne , Vantyghem Marie-Christine

Background: Lamin A/C mutations show heterogeneous phenotypes expanding from cardiopathies to lipodystrophies. R482-LMNA gene mutation is the hot-spot for familial partial lipodystrophic syndromes (FPLD2) and is characterized by an increase of intra-abdominal (visceral) fat. In contrast, the visceral fat phenotype of non-R482-LMNA mutated patients has not been well studied.Objectives: To compare the fat amount and visceral repartition o...